EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ion channels in lung cancer: biological and clinical relevance

Chiara Capitani, Ginevra Chioccioli Altadonna, Michele Santillo, Elena Lastraioli

Frontiers in Pharmacology · 24.10.2023 · 14

DOI: 10.3389/fphar.2023.1283623 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.10.2023. Verfasst von Chiara Capitani und 3 weiteren Autor:innen. Beteiligte Einrichtung: General Pathology Laboratory, Department of Experimental and Clinical Medicine, Internal Medicine Section, University of Florence, Florence, Italy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite improvements in treatment, lung cancer is still a major health problem worldwide. Among lung cancer subtypes, the most frequent is represented by adenocarcinoma (belonging to the Non-Small Cell Lung Cancer class) although the most challenging and harder to treat is represented by Small Cell Lung Cancer, that occurs at lower frequency but has the worst prognosis. For these reasons, the standard of care for these patients is represented by a combination of surgery, radiation therapy and chemotherapy. In this view, searching for novel biomarkers that might help both in diagnosis and therapy is mandatory. In the last 30 years it was demonstrated that different families of ion channels are overexpressed in both lung cancer cell lines and primary tumours. The altered ion channel profile may be advantageous for diagnostic and therapeutic purposes since most of them are localised on the plasma membrane thus their detection is quite easy, as well as their block with specific drugs and antibodies. This review focuses on ion channels (Potassium, Sodium, Calcium, Chloride, Anion and Nicotinic Acetylcholine receptors) in lung cancer (both Non-Small Cell Lung Cancer and Small Cell Lung Cancer) and recapitulate the up-to-date knowledge about their role and clinical relevance for a potential use in the clinical setting, for lung cancer diagnosis and therapy.

Schlagwörter

Stichwörter der Autor:innen

NSCLCSCLCanion channelscalcium channelschloride channelslung cancerpotassium channelssodium channels

Autor:innen und Institutionen

  • General Pathology Laboratory, Department of Experimental and Clinical Medicine, Internal Medicine Section, University of Florence, Florence, Italy.
  • Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Zitieren

APA

Capitani, C., Chioccioli Altadonna, G., Santillo, M., & Lastraioli, E. (2023). Ion channels in lung cancer: biological and clinical relevance. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1283623

Vancouver

Capitani C, Chioccioli Altadonna G, Santillo M, Lastraioli E. Ion channels in lung cancer: biological and clinical relevance. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1283623

BibTeX
@article{Capitani2023,
  author = {Capitani, Chiara and Chioccioli Altadonna, Ginevra and Santillo, Michele and Lastraioli, Elena},
  title = {Ion channels in lung cancer: biological and clinical relevance},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1283623}
}
Kostenlos starten →